Interest in PD-L1 at AACR 2025

Hello Scientist,

Another busy AACR is in the books! We followed several interesting topics this year, but notably PD-L1 was one of the most frequently studied targets of interest.

Benchmark Antibodies has now expanded the premium IVD for R&D reagent catalogue to include diagnostic grade PD-L1 antibody clones:

IVD for R&D precision antibodies are developed by pathologists to provide diagnostic grade target specificity and reproducibility validated reagents for your IHC research applications.

Why use IVD reagents for research applications? The IVD for R&D clones are invaluable for eliminating the guess-work and inconsistencies of research grade reagents.

RELIABLE QUALITY – ISO/GMP monoclonal manufacturing and IVD validation guarantees batch consistency and reproducibility ECONOMICAL – IVD workflow reagents ensure uninterrupted supply and lowest market prices EASY-TO-USE – Well characterized protocols with real-time North American technical support and order fulfillment	Human lung adenocarcinoma. Human lung adenocarcinoma stained with anti-PD-L1 (Clone ZR3) using peroxidase-conjugate and DAB chromogen. Note membranous staining of tumor cells. TECHNICAL RESOURCES: Immunohistochemistry Protocol Anti-PD-L1 rabbit monoclonal antibody (ZR3) 6328

Please visit us and feel free to contact us if you have any questions or if we can provide you with additional information.
We look forward to hearing from you!

Best regards,
Team Benchmark

Visit some of the technical resources available from Benchmark to streamline your workflows:
SAMPLE PREP GUIDES	DATA ANALYSIS TOOLS	CALCULATOR TOOLS

Visit Our Website

Contact Us

(650) 746-4228

If you no longer wish to receive these emails, click here to unsubscribe.